Strategies to Reduce Injuries and Develop Confidence in Elders (STRIDE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02475850 |
Recruitment Status :
Completed
First Posted : June 19, 2015
Results First Posted : March 3, 2021
Last Update Posted : March 3, 2021
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Accidental Falls Wounds and Injuries | Other: Evidence-based tailored fall prevention Other: Usual care | Phase 3 |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 5451 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Investigator, Outcomes Assessor) |
Primary Purpose: | Prevention |
Official Title: | Randomized Trial of a Multifactorial Fall Injury Prevention Strategy |
Actual Study Start Date : | August 2015 |
Actual Primary Completion Date : | December 2019 |
Actual Study Completion Date : | January 2020 |
Arm | Intervention/treatment |
---|---|
Fall prevention standard of care
An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the CDC's "STEADI" toolbox and the joint American Geriatrics Society/British Geriatrics Society guidelines, and ACOVE practice change approach
|
Other: Evidence-based tailored fall prevention |
Control
Usual fall prevention care
|
Other: Usual care |
- First Adjudicated Serious Fall-Related Injury [ Time Frame: Enrollment through last completed follow-up or death interview (max 44 months) ]Number of first adjudicated serious fall-related injury serious fall-related injury events per 100 per years of follow-up.
- First Self-reported Fall-related Injury [ Time Frame: Enrollment through last completed follow-up or death interview (max 44 months) ]Number of first self-reported fall-related injuries per 100 per years of follow-up
- Time to Self-reported Falls [ Time Frame: these data were not collected ]** data for this outcome was not collected
- Physical Function [ Time Frame: measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores ]Late Life Function and Disability Instrument (LL-FDI) function score. The scores are on a 0-100 scale, higher score = better function. The measure reported is the mean of scores at the 12-month and 24-months follow-up assessment
- Disability [ Time Frame: measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores ]Late Life Function and Disability Instrument (LL-FDI) disability score. The scores are on a 0-100 scale, higher score = less disability. The measure reported is the mean of scores at the 12-month and 24-months follow-up assessment
- Anxiety [ Time Frame: Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores. ]Patient-reported Outcome Measure Information System (PROMIS) Anxiety subscale. Measured on a 8-40 Scale, higher score = more anxiety.
- Depression [ Time Frame: Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores. ]PROMIS depression subscale. Measured on a 8-40 Scale, higher score = more depression.
- Fear of Falling [ Time Frame: Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores. ]Falls Efficacy Scale. Measured on a 10-40 Scale, higher score = more fear of falling.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 70 Years and older (Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- The patient is at least 70 years of age.
- The patient must answer 'yes' to one or more of the following questions:
- Have you fallen and hurt yourself in the past year?
- Have you fallen 2 or more times in the past year?
- Are you afraid that you might fall because of balance or walking problems?
Exclusion Criteria:
- The patient is enrolled in hospice.
- The patient resides in a nursing home.
- The patient is not capable of providing informed consent (or assent), and a proxy is not available.
- The patient does not speak English or Spanish

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02475850
United States, California | |
Healthcare Partners | |
Torrance, California, United States | |
United States, Iowa | |
University of Iowa Health Alliance | |
Des Moines, Iowa, United States | |
United States, Maryland | |
Johns Hopkins Medicine | |
Baltimore, Maryland, United States | |
United States, Massachusetts | |
Partners Healthcare | |
Boston, Massachusetts, United States | |
Reliant Medical Group | |
Worcester, Massachusetts, United States | |
United States, Michigan | |
University of Michigan | |
Ann Arbor, Michigan, United States | |
United States, Minnesota | |
Essentia Health | |
Duluth, Minnesota, United States | |
United States, New York | |
Mt Sinai Health System | |
New York, New York, United States | |
United States, Pennsylvania | |
University of Pittsburgh | |
Pittsburgh, Pennsylvania, United States | |
United States, Texas | |
University of Texas Medical Branch at Galveston | |
Galveston, Texas, United States |
Principal Investigator: | Shalender Bhasin, MD | Brigham and Women's Hospital | |
Principal Investigator: | Thomas Gill, MD | Yale University | |
Principal Investigator: | Dave Reuben, MD | University of California, Los Angeles | |
Study Director: | Nancy Latham, PhD | Brigham and Women's Hosptial |
Documents provided by Nancy Latham, Brigham and Women's Hospital:
Responsible Party: | Nancy Latham, Study Director, Brigham and Women's Hospital |
ClinicalTrials.gov Identifier: | NCT02475850 |
Other Study ID Numbers: |
U01AG048270 ( U.S. NIH Grant/Contract ) 1U01AG048270-01 ( U.S. NIH Grant/Contract ) |
First Posted: | June 19, 2015 Key Record Dates |
Results First Posted: | March 3, 2021 |
Last Update Posted: | March 3, 2021 |
Last Verified: | March 2021 |
Wounds and Injuries |